Anxiety and depression symptoms correlate with metabolic indicators in metabolic dysfunction-associated steatotic liver disease patients

Table 1 General characteristics of study subjects

Item	Classification	n (%)
Gender
	Male	198 (60.4)
	Female	130 (39.6)
Age (years)
	< 40	78 (23.8)
	40-59	186 (56.7)
	≥ 60	64 (19.5)
Education level
	Elementary school and below	38 (11.6)
	Junior high school	92 (28.0)
	High school or secondary vocational	118 (36.0)
	Junior college and above	80 (24.4)
Marital status
	Married	284 (86.6)
	Unmarried	26 (7.9)
	Divorced or widowed	18 (5.5)
Occupation type
	Mental labor	142 (43.3)
	Physical labor	116 (35.4)
	Retired or unemployed	70 (21.3)
MASLD disease duration (years)	mean ± SD	3.8 ± 2.6
Smoking
	Yes	118 (36.0)
	No	210 (64.0)
Alcohol consumption
	Yes	94 (28.7)
	No	234 (71.3)
Regular exercise habits
	Yes	86 (26.2)
	No	242 (73.8)
Comorbid hypertension
	Yes	156 (47.6)
	No	172 (52.4)
Comorbid type 2 diabetes
	Yes	128 (39.0)
	No	200 (61.0)
Comorbid dyslipidemia
	Yes	246 (75.0)
	No	82 (25.0)
Comorbid metabolic syndrome
	Yes	198 (60.4)
	No	130 (39.6)
Imaging grading
	Mild fatty liver	142 (43.3)
	Moderate fatty liver	126 (38.4)
	Severe fatty liver	60 (18.3)

MASLD: Metabolic dysfunction-associated steatotic liver disease.